VH declares grants or contracts to their institution from Merck, Amgen, Roche, Celgene, Boehringer-Ingelheim, Sirtex, Shire, and Servier; consulting fees from Merck, Roche, AstraZeneca, GSK, Celgene, Amgen, Servier, Novartis, Pierre-Fabre, Halozyme, MSD, BMS, Janssen, Terumo, Sirtex, Oncosil, Nordic Pharma, and Boehringer-Ingelheim; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Merck, AstraZeneca, GSK, Amgen, Roche, Sanofi, Servier, Pfizer, Pierre-Fabre, BMS, MSD, Novartis, Boehringer-Ingelheim, Celgene, Sirtex, and Seagen; support for attending meetings or travel from Merck, Nordic Pharma, AstraZeneca, GSK, Amgen, and MSD; and has participated on a data safety monitoring board or advisory board for ICON. SS declares grants or contracts to their institution from Merck, Pierre-Fabre, and Roche; consulting fees from Amgen, AstraZeneca, Bayer, Lilly, Merck, MSD, Pierre-Fabre, Roche, Sanofi, Servier, Taiho, CV6, and Isofol; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Amgen, AstraZeneca, Bayer, Lilly, Merck, MSD, Pierre-Fabre, Roche, Sanofi, Servier, and Taiho; support for attending meetings or travel from Amgen, AstraZeneca, Bayer, Lilly, Merck, MSD, Pierre-Fabre, Roche, Sanofi, Servier, and Taiho; and has participated on a data safety monitoring board or advisory board for CV6 and Isofol.